agilon health, inc.
AGL
$2.89
-$0.33-10.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.53B | 1.52B | 1.45B | 1.48B | 1.60B |
| Total Other Revenue | 2.90M | 3.24M | 3.24M | 3.18M | 3.16M |
| Total Revenue | 1.53B | 1.52B | 1.45B | 1.48B | 1.60B |
| Cost of Revenue | 1.48B | 1.56B | 1.52B | 1.45B | 1.53B |
| Gross Profit | 50.72M | -38.26M | -64.17M | 32.18M | 75.09M |
| SG&A Expenses | 65.43M | 59.91M | 61.67M | 68.74M | 74.01M |
| Depreciation & Amortization | 6.88M | 6.49M | 6.22M | 5.91M | 5.84M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.55B | 1.63B | 1.58B | 1.53B | 1.61B |
| Operating Income | -21.59M | -104.66M | -132.06M | -42.48M | -4.76M |
| Income Before Tax | -1.69M | -104.67M | -117.02M | -30.25M | 3.11M |
| Income Tax Expenses | 196.00K | 1.76M | -590.00K | 417.00K | -133.00K |
| Earnings from Continuing Operations | -1.89M | -106.43M | -116.43M | -30.66M | 3.25M |
| Earnings from Discontinued Operations | 14.00M | 640.00K | -1.18M | -- | -9.28M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | -- | -20.00K | -30.00K |
| Net Income | 12.11M | -105.79M | -117.62M | -30.68M | -6.06M |
| EBIT | -21.59M | -104.66M | -132.06M | -42.48M | -4.76M |
| EBITDA | -14.71M | -98.17M | -125.84M | -36.57M | 1.08M |
| EPS Basic | 0.03 | -0.26 | -0.29 | -0.07 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.15 | -0.18 | -0.04 | 0.01 |
| EPS Diluted | 0.03 | -0.26 | -0.29 | -0.07 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.15 | -0.18 | -0.04 | 0.01 |
| Average Basic Shares Outstanding | 412.94M | 412.04M | 411.59M | 411.27M | 408.94M |
| Average Diluted Shares Outstanding | 412.94M | 412.04M | 411.59M | 411.27M | 408.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |